ISSN: 0256-1115 (print version) ISSN: 1975-7220 (electronic version)
Copyright © 2024 KICHE. All rights reserved

Articles & Issues

Language
English
Conflict of Interest
In relation to this article, we declare that there is no conflict of interest.
Publication history
Received May 20, 2016
Accepted September 23, 2016
articles This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.

All issues

Ceramide-based nanostructured lipid carriers for transdermal delivery of isoliquiritigenin: Development, physicochemical characterization, and in vitro skin permeation studies

Cosmetic R&D Center, Department of Fine Chemistry, Cosmetic Industry Coupled Collaboration Center, Seoul National University of Science and Technology, 232 Gongneung-ro, Nowon-gu, Seoul 01811, Korea
snpark@seoultech.ac.kr
Korean Journal of Chemical Engineering, February 2017, 34(2), 400-406(7), 10.1007/s11814-016-0267-3
downloadDownload PDF

Abstract

An optimized, ceramide-based, nanostructured lipid carrier (NLC) formulation was developed for isoliquiritigenin (ILTG), and its potential as a transdermal delivery system was evaluated. ILTG-loaded NLCs were prepared by blending solid (ceramide, cholesterol) and liquid lipids (caprylic/capric triglyceride) in various proportions using a hot homogenization and ultrasonication method. The physicochemical characteristics were investigated by DLS, ZP, EE%, TEM, DSC and XRD analyses and in vitro skin permeation studies. The results showed that the particle size of the formulation was 150.19-251.69 nm with a ZP>-20mV. The EE% was 56.45-89.97%. The NLC structure was influenced by lipid ratio, and increasing the caprylic/capric triglyceride ratio caused a less ordered structure, as confirmed by DSC. The XRD analysis indicated that ILTG was not in the crystalline state in all formulations. The skin permeation study showed that the ILTG-NLCs promoted ILTG permeation. In conclusion, ceramide-based NLCs could be a promising vehicle for the ILTG transdermal delivery of ILTG.

References

Wertz PW, Bergh B, Chem. Phys. Lipids, 91, 85 (1988)
Grayson S, Elias PM, J. Invest. Dermatol., 78, 128 (1982)
Nardo AD, Wertz P, Giannetti A, Seidenari S, Acta. Derm. Venereol. Suppl, 78, 27 (1998)
Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R, Arch. Dermatol. Res., 130, 452 (1994)
Perisho K, Wertz PW, Madison KC, Stewart ME, Downing DT, J. Invest. Dermatol., 90, 350 (1988)
Abraham W, Downing DT, Pharm. Res., 9, 1415 (1992)
Park SN, Lee MH, Kim SJ, Yu ER, Biochem. Biophys. Res. Commun., 435(3), 361 (2013)
Kim DH, Park WR, Kim JH, Cho EC, An EJ, Kim JW, Oh SG, Colloids Surf. B: Biointerfaces, 94, 236 (2012)
Wu X, Guy RH, J. Drug. Deliv. Sci. Technol., 19, 371 (2009)
Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Int. J. Pharm., 477, 601 (2014)
Choi WS, Cho HI, Lee HY, Lee SH, Choi YW, J. Pharm. Invest., 40, 373 (2010)
Pardeike J, Hommoss A, Muller RH, Int. J. Pharm., 366, 170 (2009)
Muller RH, Radtke M, Wissing SA, Int. J. Pharm., 242, 121 (2002)
Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V, Nanomedicine, 12, 143 (2016)
Zhao X, Mei W, Gong M, Zuo W, Bai H, Dai H, Molecules, 169, 775 (2011)
Zhang X, Yeung ED, Wang J, Panzhinskiy EE, Tong C, Li W, Li J, Clin. Exp. Pharmacol. Physiol., 37, 841 (2010)
Nerya O, Vaya J, Musa R, Izrael S, Ben-Arie R, Tamir S, J. Agric. Food Chem., 51, 1201 (2003)
Kim SC, Byun SH, Yang CH, Kim CY, Kim JW, Kim SG, Toxicology, 197, 239 (2004)
Zhang XY, Qiao H, Ni JM, Shi YB, Qiang Y, Eur. J. Pharm. Sci., 49, 411 (2013)
Kim SJ, Kwon SS, Jeon SH, Yu ER, Park SN, Int. J. Cosmet. Sci., 36, 553 (2014)
Jeon SH, Yoo CY, Park SN, Colloids Surf. B: Biointerfaces, 129, 7 (2015)
Kwon SS, Kim SY, Kong BJ, Kim KJ, Noh GY, Im NR, Lim JW, Ha JH, Kim J, Park SN, Int. J. Pharm., 483, 26 (2015)
Kwon SS, Kong BJ, Park SN, Eur. J. Pharm. Biopharm., 92, 146 (2015)
Jeong YM, Ha JH, Park SN, J. Ind. Eng. Chem., 35, 54 (2016)
Teeranachaideekul V, Boonme P, Souto EB, Muller RH, Junyaprasert VB, J. Control. Release, 128, 134 (2008)
Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K, J. Control. Release, 95, 217 (2004)
Fang JY, Fang CL, Liu CH, Su YH, Eur. J. Pharm. Biopharm., 70, 633 (2008)
Muller RH, Jacobs C, Kayser O, Adv. Drug Deliv. Rev., 47, 3 (2001)
Rodrigues LR, J. Colloid Interface Sci., 449, 304 (2015)
Ranpise NS, Korabu SS, Ghodake VN, Colloids Surf. B: Biointerfaces, 116, 81 (2014)
Kuo YC, Chen HH, Int. J. Pharm., 365, 206 (2009)
Gaur PK, Mishra S, Verma A, Verma N, J. Exp. Nanosci., 11, 38 (2016)
Shah R, Eldridge D, Palombo E, Harding I, SpringerInternational Publishing (2015).
Kovacevic A, Savic S, Vuleta G, Muller RH, Keck CM, Int. J. Pharm., 406, 163 (2011)
Han SB, Kwon SS, Jeong YM, Yu ER, Park SN, Int. J. Cosmet. Sci., 36, 588 (2014)
Li B, Liu B, Li J, Xiao H, Wang J, Liang G, Int. J. M. Sci., 16, 17999 (2015)
Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K, Int. J. Pharm., 477, 601 (2014)
Shamma RN, Aburahma MH, Int. J. Nanomedicine, 9, 5449 (2014)
Pradhan M, Singh D, Singh MR, Chem. Phys. Lipids, 186, 9 (2015)
Chen H, Wang Y, Zhai Y, Zhai G, Wang Z, Colloids Surf. A: Physicochem. Eng. Asp., 465, 130 (2015)
Souto EB, Wissing SA, Barbosa CM, Muller RH, Int. J. Pharm., 278, 71 (2004)
Zhai Y, Zhai G, J. Control. Release, 193, 90 (2014)

The Korean Institute of Chemical Engineers. F5, 119, Anam-ro, Seongbuk-gu, 233 Spring Street Seoul 02856, South Korea.
TEL. No. +82-2-458-3078FAX No. +82-507-804-0669E-mail : kiche@kiche.or.kr

Copyright (C) KICHE.all rights reserved.

- Korean Journal of Chemical Engineering 상단으로